Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Warts × Granulocyte Colony-Stimulating Factor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Warts 1 Recurrence 1 Neutropenia 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Infections 1 Immunologic Deficiency Syndromes 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Agammaglobulinemia 1

Interventions

plerixafor 1 Tuberculin 1 Salicylic Acid 1 Pyruvic Acid 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02231879 2023-04-07

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

National Institutes of Health Clinical Center (CC)

Phase 2/3 Completed

20 enrolled 10 charts

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Neutropenia, Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡